What is Corbus Pharmaceuticals (CRBP)?
Corbus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of inflammatory and fibrotic diseases. The company utilizes a proprietary platform to develop drugs that target the endocannabinoid system and other pathways involved in disease progression. Its research pipeline includes compounds aimed at conditions such as systemic sclerosis, cystic fibrosis, and dermatomyositis. Corbus Pharmaceuticals engages in collaborations and partnerships to advance its clinical programs and expand its scientific knowledge base. The company operates within the biotechnology sector, emphasizing innovation in drug discovery and development to address unmet medical needs.
Corbus Pharmaceuticals Stock Price Today: Live Overview
The price today is shaped by the latest trading activity, with Corbus Pharmaceuticals currently at $9.514. During the session, it has moved between $9.176 and $9.746, with a daily change of 0%.
FAQ: Corbus Pharmaceuticals (CRBP)
What is the current price of CRBP stock?
The current price of Corbus Pharmaceuticals is $9.514.
Does CRBP pay dividends?
Dividends are not paid by the company.
Does CRBP have a formal corporate presence or regional headquarters in the UAE?
Corbus Pharmaceuticals does not have an official regional office, subsidiary, or registered presence in the UAE and operates through partners and distributors.
What is CRBP best known for?
The company is most famous for its development of therapies targeting inflammatory and fibrotic diseases.
What assets are typically shown together with CRBP?
Commonly shown alongside CRBP: Brookdale Senior Living Inc, United Therapeutics Corp, Toast, Inc.
Latest shares articles



